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Abstract
Background: During the last decade, investigations have focused on revealing genes or proteins
that are involved in HCC carcinogenesis using either genetic or proteomic techniques. However,
these studies are overshadowed by a lack of good internal reference standards. The need to identify
"housekeeping" markers, whose expression is stable in various experimental and clinical conditions,
is therefore of the utmost clinical relevance in quantitative studies. This is the first study employed
2-DE analysis to screen for potential reference markers and aims to correlate the abundance of
these proteins with their level of transcript expression.
Methods: A Chinese cohort of 224 liver tissues samples (105 cancerous, 103 non-tumourous
cirrhotic, and 16 normal) was profiled using 2-DE analysis. Expression of the potential reference
markers was confirmed by western blot, immunohistochemistry and real-time quantitative PCR.
geNorm algorithm was employed for gene stability measure of the identified reference markers.
Results: The expression levels of three protein markers beta-actin (ACTB), heat shock protein 60
(HSP60), and protein disulphide isomerase (PDI) were found to be stable using p-values (p > 0.99)
as a ranking tool in all 224 human liver tissues examined by 2-DE analysis. Of high importance,
ACTB and HSP 60 were successfully validated at both protein and mRNA levels in human hepatic
tissues by western blot, immunohistochemistry and real-time quantitative PCR. In addition, no
significant correlation of these markers with any clinicopathological features of HCC and cirrhosis
was found. Gene stability measure of these two markers with other conventionally applied
housekeeping genes was assessed by the geNorm algorithm, which ranked ACTB and HSP60 as the
most stable genes among this cohort of clinical samples.
Conclusion: Our findings identified 2 reference markers that exhibited stable expression across
human liver tissues with different conditions thus should be regarded as reliable reference moieties
for normalisation of gene and protein expression in clinical research employing human hepatic
tissues.
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Quantitative proteomic and genomic technologies have
recently revolutionized the search for disease-specific
biomarkers or molecular signatures that allow early prog-
nosis and accurate detection of illness. Functional studies
of these gene and protein biomarkers also facilitate our
better understanding of pathogenesis pathways in relation
to disease onset and progression (e.g. carcinogenesis and
tumour metastasis) [1-3]. However, we often encounter
the unwanted scenario that associates biological variabil-
ity in clinical specimens with respect to the corresponding
disease phenotypes and tissue qualities at the time of col-
lection [4,5]. These intrinsic factors significantly hinder
data analysis and accurate interpretation in genome- and
proteome-wide expression profiling studies [2]. To better
decipher biological and experimental variations, the
inclusion of certain specifically selected internal reference
control(s) for data standardization or normalization can
facilitate accurate biomarker comparisons.
Ideally, a "good" internal reference marker is expected to
show a constant level of expression presence across all tis-
sue samples of the same type and of the same experimen-
tal design and treatment. Nevertheless, there is mounting
evidence that the conventional transcripts or proteins
used as ubiquitous internal house-keeping controls such
as glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
beta-actin and beta-tubulin, are often variable in expres-
sion levels across different sample types and experimental
conditions [6-8]. In this regard, there are unmet needs to
identify and validate a set of stable reference markers for
data standardization in human liver tissues.
The availability of protein reference markers for quantita-
tive comparison is perhaps more enigmatic than tran-
scriptional counterparts. This is largely contributed by
differential extraction and binding efficiencies affecting
measurement of proteins, plus analytical measurement
anomalies which are largely absent with transcript meas-
urement. To date, the expression stabilities of conven-
tional reference protein markers have not yet been
examined systemically in human liver tissues and during
the pathogenic course of tissue transformation from the
healthy or preneoplastic (cirrhosis) conditions to the can-
cerous stage (hepatocellular carcinoma, HCC) [8]. This
inevitably affects an accurate prediction of the protein
expression profiles among different clinical samples, par-
ticularly when data normalization is based on the internal
controls that are considered likely to be sub-optimal in
their expression stabilities. To address this deficiency, we
employed the 2-DE based proteomic approach to search
for potential reference protein markers whose expression
levels are evenly present in clinical specimens obtained
from HCC tumours, cirrhosis and healthy livers, hereafter
confirmed by quantitative approaches. In fact, the general
correlation between protein and transcript expression
remains unclear and without consensus, the candidate ref-
erence markers were further subjected to cross-examina-
tion together with other conventional reference gene
markers by employing the geNorm algorithm in order to
determine the corresponding gene expression stabilities.
Methods
Clinical samples
A total of 224 resected clinical liver samples (105
tumours, 103 non-tumourous cirrhotic and 16 normal)
were collected from patients with informed consent after
surgical operation at the Department of Surgery, Queen
Mary Hospital (Pokfulam, Hong Kong) between 1998
and 2005.
Two-dimensional gel electrophoresis (2-DE) and mass 
spectrometry (MS)
Sample preparation and the 2DE procedure were per-
formed as previously described [9]. In brief, proteins were
extracted from 20 mg liver tissue samples using the Read-
yPrep™ Sequential Extraction Kit (Bio-Rad, Hercules, CA,
USA) and protein concentration of the lysates was quanti-
fied using the PlusOne 2-DE Quant Kit (GE Biosciences,
Buckinghamshire, England). Isoelectric focusing was car-
ried out using a 30 μg aliquot of protein lysate placed on
a 11 cm strip (pH 4-7) (GE Biosciences), with running
conditions performed as described [9]. For the second
dimension gel electrophoresis, the proteins were resolved
on 1 mm thick 12.5% precast gels that were separated
overnight under a constant current of 10 mA per gel in an
Ettan™ DALTsix Electrophoresis Unit (GE Biosciences) at
10°C. After gel fixation and silver staining (GE Bio-
sciences), the protein expression patterns resolved on the
gels were captured with a GS-800 Calibrated Densitome-
ter (Bio-Rad) and the images were analysed using
PDQuest version 8.0 (Bio-Rad). The intensity of each spot
was normalised by total valid spot volume and was
reported as a relative value in ppm.
The selected protein spots were digested in gel according
to the method described by Yi, X et al [10] using MS grade
trypsin (Promega, Madison, WI, USA). The peptide
masses were determined using a MALDI-TOF mass spec-
trometer. Full scan and product ion-mass spectra were
acquired on a hybrid quadrupole-time of flight mass spec-
trometer (QSTAR-XL™ or Voyager-DE™ STR, Applied Bio-
systems Inc., Foster City, CA). The tandem mass spectra
were collected in product ion mode for the peptides of
interest. Measured peptide and fragment ion masses were
used for protein identification by two online programs:
MS-FIT http://prospector.ucsf.edu and MASCOT http://
www.matrixscience.com.Page 2 of 11
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Verification of protein content and quantity was carried
out in a new set of 20 liver tissues which included 4 cir-
rhosis, 4 paired tumour and peri-tumour of less than 2
cm; 4 paired tumour and peri-tumour of greater than 2
cm. Protein extracts were prepared as previously described
[10]. Extracted protein lysates were subjected to 10% SDS-
PAGE electrophoreses and transferred to a nitrocellulose
membrane. Tris-buffered saline (TBS) containing 5%
non-fat milk was used for blocking 1 h at room tempera-
ture before incubation with primary rabbit polyclonal
anti-HSP 60 (1:1000 dilutions) and mouse monoclonal
anti-beta-actin antibodies (1:1000 dilutions) (Cell signal-
ling technology, Danvers, MA, USA and Sigma, St. Louis,
MO, USA respectively). The blots were washed and incu-
bated with horseradish peroxidise-conjugated secondary
antibodies (1:10,000 dilutions) followed by the develop-
ment with ECL detection system (GE Biosciences). Densi-
tometry data were analysed by Quantity One (Bio-Rad)
for semi-quantification of HSP 60 and beta-actin.
Immunohistochemistry
To further confirm the results from the 2-DE, immunohis-
tochemical analyses on pathologist reviewed tissue sec-
tions were executed as previously described [11].
Endogenous peroxidase activities of the sections were
quenched with 3% hydrogen peroxide and the sections
were blocked using 1% bovine serum albumin (BSA) (w/
v in PBS). Antibodies against β-actin (Sigma) and HSP60
(Stressgen Biotechnologies, Victoria, Canada) were added
separately to the tissue sections, which were then incu-
bated at 4°C overnight. Thereafter, the sections were incu-
bated with horseradish peroxidase-conjugated goat anti-
mouse immunoglobulin for 30 minutes at room temper-
ature. The signal was detected using a ready-to-use DAKO
EnVision™ system (Dako, Glostrup, Denmark). The sec-
tions were subsequently counterstained with haematoxy-
lin (Vector Laboratories, Burlingame, CA, USA) and
viewed at five different fields per section using light micro-
scopy. For the negative isotype controls, the primary anti-
body was replaced with a purified mouse
immunoglobulin (1:500 dilution, Zymed-Invitrogen,
Carlsbad, CA, USA). The images were captured with a
Nikon epifluorescent upright microscope E600 (Nikon,
Tokyo, Japan).
SYBR Green I quantitative PCR (Q-PCR)
To validate the gene expression stability of the two poten-
tial reference marker candidates (ACTB, HSP60), real-time
monitoring of the PCR reactions was performed according
to standard procedures as described previously [10]. Total
RNA was extracted from tissue samples by TRIzol reagent
(Invitrogen, Carlsbad, CA, USA), followed by treatment
with DNase I (Ambion, Austin, TX), and subsequently the
amount and quality were determined by 2100 Bioana-
lyzer (Agilent Technologies, Inc., Santa Clara, CA, USA).
Approximately 250 ng of DNase-treated RNA was used for
RT reaction. The oligonucleotide primers for ACTB and
HSP60 were designed using the ABI PRISM Primer Express
Software (Applied Biosystems) (see Additional file
1).HMBS was used as an internal control, seeing that a
recent publication from Cicinnati's group suggested that
HMBS was found to be the single best reference gene for
gene expression studies in HCC [12]. The fluorescence
dyes, SYBR Green I was used as signal reporters to benefit
a gain in sensitivity for signal detection.
Q-PCR with fluorescent resonance energy transfer (FRET) 
hydrolysis probes
To test the gene expression stability of the two markers, Q-
PCR was performed using FRET hydrolysis probes in order
to gain in specificity for subsequently analysis. Primer and
probe sequences were designed for the six most com-
monly used reference genes obtained from published lit-
erature: beta-2-microglobulin (B2M), hypoxanthine
phosphoribosyl-transferase I (HRPT1), ribosomal protein
L32 (RPL32), succinate dehydrogenase complex, subunit
(SDHA), hydroxymethyl-bilane synthase (HMBS), ribos-
omal protein L13a (RPL13A); and the two reference mark-
ers identified in this study: beta-actin (ACTB) and heat
shock protein 60 (HSP60) using the Universal Probe
Library Assay Design Centre http://www.roche-applied-
science.com (see Additional file 2). The accession num-
bers, functions, and chromosomal locations of these
genes were also tabulated (see Additional file 3). The
expression level of these 8 reference genes was assessed in
40 human liver samples (10 advanced stage HCC, 10 early
stage HCC, 10 cirrhosis, and 10 normal liver tissues). The
real-time assays were performed in triplicate using the
Roche LightCycler 480 (Roche Diagnostic Ltd, UK). Ther-
mal cycling was operated in the fast mode and the cycling
parameter was as follows: 40 cycles of 95°C for 10 sec-
onds and 60°C for 30 seconds. Real-time data was ana-
lysed using the Roche LightCycler 480 software (Roche
Diagnostic Ltd).
Statistical analysis
The 2D gel spot intensities were statistically analysed by
SPSS Statistical Package version 13.0 for Window (SPSS,
Chicago, IL) to perform one-way Analysis of Variance
(ANOVA). P value (> 0.99) was employed purely as a
ranking tool to identify proteins with potentially low var-
iability across different diagnostic groups and does not
imply any measure of statistical significance.
The stability of the reference transcripts was calculated
using the geNorm algorithm described by Vandesompele
et al. [13]. The CT value for each reference transcript was
converted into a relative quantity, which was subse-
quently used to calculate the gene stability value (M). InPage 3 of 11
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between candidate reference transcripts. This value acts as
a parameter for denoting the optimum number of refer-
ence transcripts to be used when the expression level of
certain transcripts are assayed in a specific cohort of clini-
cal specimens.
Results
Beta-actin, HSP60, and PDI as putative reference markers 
in human liver tissues
In this study, the 2-DE expression profiles of tumourous,
non-tumourous cirrhotic and normal liver proteomes are
depicted (Figure 1). We found 1,433 proteins in human
liver tissues on the 2-DE gel. After gel-to-gel matching and
normalization, one-way ANOVA was performed and p-
value analysis was used as a ranking tool to identify pro-
teins with potentially low variability across different ana-
lysed groups. Three protein spots, labelled as SSP3412,
SSP4503, and SSP6510, were selected based on their
mean, standard deviation, 95% confidence interval and
the calculated p values, suggested that these proteins
exhibited a high rank with low expression variation across
the tumourous, non-tumourous cirrhotic, and normal
liver tissues (0.997, 0.990 and 0.993, respectively).
Often the mean value is quoted along with the standard
deviation to describe the population distribution, where
the mean summarises the central location of the data and
the standard deviation shows the spread. Table 1 shows
the mean and standard deviation of each reference protein
marker candidate, mean intensities in ppm were more or
less 7 in the three diagnostic groups with a low standard
Identification of beta-actin, HSP60, and PDI as potential housekeeping markersFigure 1
Identification of beta-actin, HSP60, and PDI as potential housekeeping markers. The protein expression profile of 
liver tissue on a 2-DE gel is shown, and the zones with the protein markers, beta-actin (SSP3412), HSP 60 (SSP4503), and PDI 
(SSP6510), are square-bracketed. Representative gel images and the histograms illustrating the relative protein intensities (in 
ppm) of SSP3412, SSP4503 and SSP6510 among tumourous, T (n = 105), non-tumourous cirrhotic, NT (n = 103), and normal, 
N (n = 16) liver tissues are shown. Statistical analysis was performed by one-way ANOVA and p value was used as a ranking 
system for expression variability. Data are presented as the mean ± SD.Page 4 of 11
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tion. Moreover, 95% confidence interval also suggested
that the population to possess a similar spread. To further
justified the potential use of the three selected reference
markers, overall measure of the variability was performed
based on their mean, standard deviation and 95% CI of
the combined groups (cancerous, non-tumourous cir-
rhotic, and normal). Results unambiguously verified the
reliability of the choice of selection.
Thus, these three protein spots were regarded as potential
housekeeping candidates for application as internal pro-
tein reference controls. Using tandem MS, these three pro-
teins were identified as beta-actin, HSP60, and PDI (see
Additional file 4).
Verification of beta-actin and HSP60 as stable genomic 
and proteomic reference markers
Beta-actin belongs to the actin family and is the basic
component of actin microfilaments [14]. HSP60 is a fam-
ily member of the heat shock protein family, which
includes the HSP's and glucose regulated proteins (GRP's)
[15]. PDI performs chaperone functions in the endoplas-
mic reticulum by catalysing disulphide bond formation
and isomerisation [16]. Only HSP 60 and beta-actin were
successfully confirmed for their constant expression levels
in both protein and transcript by western blot and qPCR
respectively and therefore we excluded PDI as a potential
candidate reference marker (see Additional file 5). PDIA3
(protein disulfide isomerase family A, member 3) is the gene
encoded for PDI. The two verified proteins (HSP 60 and
beta-actin) belong to distinctly different and unrelated
protein families, by 2D gel analysis their expression levels
were found to be stable in human liver tissues possessing
various stages of HCC and these results were further con-
firmed using western blotting, (Figure. 2A), immunohis-
tochemistry (Figure. 2B) and Q-PCR (Figure. 2C). The
fold ratio difference across sample types shown in Figure
2C is small, and under 0.5 for both beta-actin and HSP60,
which is in agreement with geNorm, and may well have
no biological importance. No significant difference in
their abundance and localizations were found among var-
ious samples. More importantly, expression of these refer-
ence markers was not associated with any of the
clinicopathological parameters in the HCC tumour tissues
(Table 2) and non-tumourous liver tissues (Table 3).
Gene-stability measure and pairwise variation analysis
Next, we employed the mathematical model (geNorm
algorithm) to investigate the gene expression stability of
ACTB, and HSP60, also to determine the optimal number
of reference genes that are required to perform an accurate
normalisation in a defined set of experimental specimens
[13]. The threshold cycle values (CT values) of the eight
reference genes [beta-2-microglobulin (B2M), hypoxan-
thine phosphoribosyl-transferase I (HRPT1), ribosomal
protein L32 (RPL32), succinate dehydrogenase complex,
subunit (SDHA), hydroxymethyl-bilane synthase
(HMBS), ribosomal protein L13a (RPL13A), beta-actin
(ACTB) and heat shock protein 60 (HSP60)] in each sam-
ple group were averaged and used to determine the rela-
tive quantities, and based on that, the gene stability (M)
and pair-wise variation (V) values of the reference gene in
the set of samples were calculated (see Additional file 6
and Table 4). Table 4 showed the priority ranking of the
eight reference genes according to their gene stabilities,
which were analysed by geNorm software in the com-
bined set of liver tissue samples. No other usual analytical
software (such as NormFinder) was employed because
previous experience had shown the different softwares
Table 1: Protein expression of SSP3412, SSP4503, and SSP6510 in tumourous, non-tumourous cirrhotic and normal liver tissues
Spot ID Spot identity Phenotypes Mean Intensity (ppm) 95% CI ANOVA
(p-value*)
SSP3412 Beta-actin Tumour 7.59 ± 0.89 5.82-9.37 0.99
Non-tumour 7.61 ± 1.76 4.10-11.12
Normal 7.49 ± 1.02 5.45-9.54
Combined Groups 7.56 ± 1.22 5.12-10.00 -
SSP4503 Heat shock protein 60 Tumour 7.74 ± 0.94 5.85-9.62 0.99
Non-tumour 7.73 ± 1.55 4.62-10.84
Normal 7.55 ± 1.12 5.30-9.79
Combined Groups 7.67 ± 1.20 5.27-10.07 -
SSP6510 Protein disulphide isomerase Tumour 7.36 ± 1.08 5.20-9.52 0.99
Non-tumour 7.39 ± 1.65 4.09-10.68
Normal 7.20 ± 1.43 4.35-10.05
Combined Groups 7.32 ± 1.39 4.54-10.10 -
* P-value does not imply any measure of statistical significance; it is apply as a ranking tool to identify proteins with low variability across different 
diagnostic groups.Page 5 of 11
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60 exhibited the lowest M value in all liver tissue groups
(normal, cirrhosis and HCC) suggested that the finding
was in agreement with the protein data derived from the
2-DE profiling method as shown above, in which the pro-
teins encoded by ACTB and HSP60 were found to have
stable expression in human liver tissues. Akin to the orig-
inal publication of geNorm, a pair-wise variation value of
0.15 was used as a cut-off point that indicates the opti-
mum number of genes used for normalization in a gene
expression study with high confidence [13]. This study
showed that two reference genes provided a geNorm score
of 0.158 which was very close to the 0.15 geNorm cut-off
value. Therefore, in subsequent studies we recommend
that two reference genes would be sufficient to be
employed for normalising gene expression in human
hepatic tissues (Figure 3 and Table 4).
Table 2: The expressions of beta-actin and HSP60 in different clinicopathological subgroups of HCC tumour tissues.
Clinicopathological parameters n = 105 Beta-actin HSP60
Mean intensity (ppm) p value Mean intensity (ppm) p value
Gender
Male 89 7.60 ± 0.95 0.81a 7.77 ± 1.06 0.63a
Female 16 7.59 ± 0.93 7.70 ± 0.93
Age (years)
≥60 38 7.61 ± 0.81 0.76a 7.48 ± 0.74 0.67a
< 60 67 7.58 ± 1.01 7.76 ± 1.17
Tumour size (cm)
> 2 69 7.79 ± 0.96 0.17a 7.68 ± 0.98 0.91a
≤2 36 7.40 ± 0.89 7.79 ± 1.14
Venous infiltration
Yes 58 7.53 ± 0.71 0.61a 7.58 ± 0.73 0.36a
No 57 7.65 ± 1.01 7.89 ± 0.87
New TNM stage
Stage I-II 69 7.72 ± 1.10 0.38a 7.58 ± 0.99 0.75a
Stage III-IV 36 7.47 ± 0.84 7.70 ± 1.14
New Edmonson Grade
Well differentiated 27 7.49 ± 1.37 0.39b 7.68 ± 1.37 0.97b
Moderately differentiated 60 7.51 ± 0.94 7.76 ± 0.77
Poorly differentiated 18 7.79 ± 0.71 7.77 ± 0.73
a, analysed by independent t test; b, analysed by one-way ANOVA.
Table 3: The expressions of beta-actin and HSP60 in different clinicopathological subgroups of the non-tumourous liver tissues.
Clinicopathological parameters n = 103 Beta-actin HSP60
Mean intensity (ppm) p value Mean intensity (ppm) p value
Gender
Male 88 7.59 ± 1.93 0.77a 7.76 ± 1.76 0.55a
Female 15 7.63 ± 1.11 7.70 ± 0.79
Age (years)
≥60 34 7.82 ± 1.26 0.50a 7.89 ± 1.07 0.41a
< 60 69 7.40 ± 2.09 7.57 ± 1.91
HBsAg
Positive 89 7.70 ± 1.77 0.82a 7.87 ± 1.76 0.49a
Negative 14 7.52 ± 2.17 7.59 ± 0.92
Liver histology
Chronic active hepatitis B 34 7.94 ± 1.75 0.91b 7.45 ± 0.85 0.34b
Mildly cirrhotic 44 7.50 ± 1.01 7.72 ± 1.17
Moderately cirrhotic 22 7.69 ± 0.66 7.50 ± 0.50
Severely cirrhotic 3 7.31 ± 0.46 8.25 ± 0.42
a, analysed by independent t test; b, analysed by one-way ANOVA.Page 6 of 11
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Proteome profiling of different stages of hepatocarcino-
genesis has been well studied [9] and this has resulted in
the identification of a panel of differentially expressed
proteins at each stage. However, proteins with constant
expression during the oncogenesis of HCC have not yet
been characterized. To be eligible as a housekeeping pro-
tein, the level of the expression of the protein should not
change during cell development, in response to drug treat-
ment, or in disease. Estimation of relative expression of
genes or proteins are often made by comparison against
the internal standards which for transcriptomics using
DNA arrays or PCR, or for proteins when using western
blotting or protein arrays. For instance, western blotting is
often used for exploration and confirmation of many pro-
teins with normalisation against "housekeeping proteins"
to correct for protein loading and factors, such as transfer
efficiency [8]. Hypothetical regulation of a housekeeping
protein, e.g. between different disease status or between
different tissue types, could potentially lead to the conclu-
sion that the target protein was regulated, but actually this
was due to dysregulation of the housekeeping protein
rather than the target protein itself. This renders the iden-
tification of housekeeping proteins highly significant in
expressional studies in clinical research.
Although the specific quantities and forms of the protein
produced are highly regulated during complex cellular
translational and post-translational processes, a poor cor-
relation between mRNA and protein abundance is often
documented [17]. Given this caveat, the aim of the study
was to investigate whether protein(s) patterns of expres-
sion are constant in oncogenesis of liver cancer. These
markers were referred to as potential housekeeping pro-
teins, which can be isolated and identified using a pro-
teomic platform and hereafter correlated with their mRNA
abundance.
In the present study, we have employed the 2-DE-based
proteomic approach to investigate 224 liver proteomes
which represented various clinical conditions. We have
successfully identified certain reference protein markers
that were evenly expressed in liver tissues among the
healthy, cirrhotic and malignant states by employing p-
value as a ranking system; and comparing the variability
using the mean, standard deviation and 95% CI. Method-
ology was kept in the linear range from sample prepara-
tion, to gel silver staining. In addition, the background of
each gel was compared by two experienced operators
independently to assess the similarity of protein spots and
normalised using PDQuest (Bio-Rad) before proceeding
to analysis. The three most stable markers were character-
ized by MALDI-TOF/MS as beta-actin (ACTB), heat shock
Stability validation of potential housekeeping markers in protein and gene levelsFigure 2 (see previous page)
Stability validation of potential housekeeping markers in protein and gene levels. (A) Western blot demonstrated 
the expression stability of beta-actin and HSP 60. An equal amount of 25 μg of protein lysate was loaded per lane in order to 
measure the expression stability of beta-actin and HSP 60 among liver tissues with different conditions. Representative blot 
images were showed parallel to the histograms with protein intensities analysed in different liver tissues groups. C, Cirrhosis; < 
2 cm, small size [less than (<) 2 cm] paired tumour (T) and non-tumour (NT); > 2 cm, large size [greater than (>) 2 cm] paired 
tumour (T) and non-tumour (NT). Statistical analysis was performed by one-way ANOVA. Data are presented as the mean ± 
SD. (B) Immunohistochemical staining showed the localizations and the levels of expression of beta-actin and HSP60 in 
tumourous, T (n = 30); non-tumourous cirrhotic, NT (n = 30); and normal, N (n = 16) liver tissues. Representative photos are 
shown (magnification: ×400). (C) Real-time qPCR was performed to evaluate the mRNA levels of beta-actin and HSP60 in 
tumourous, T (n = 20); non-tumourous cirrhotic, NT (n = 20); and normal, N (n = 16) liver tissues. Statistical analysis was per-
formed by one-way ANOVA (p > 0.05). Data are presented as the mean ± SD.
Table 4: The ranking of reference gene expression stability in set of human liver tissues
Ranking order* HCC, Cirrhosis 
and Normal
M V
8 HPRT1 0.94 0.147
7 SDHA 0.82 0.134
6 B2M 0.74 0.147
5 RPL13A 0.63 0.132
4 HMBS 0.55 0.131
3 RPL32 0.51 0.158
The 2 most stably expressed genes ACTB, HSP60 0.47
Gene stability increased from top to bottom; M, gene stability value; V, pairwise stability valuePage 8 of 11
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(PDI), and the corresponding expression patterns were
further determined by western blot, immunohistochemis-
try and Q-PCR. However, only ACTB and HSP 60 had
been successfully fulfilled the complete validation process
which included transcript expression. Herein, we postu-
late these two markers to be active participants in the nor-
mal physiological functions and do not possess essential
roles in liver cirrhosis and hepatocarcinogenesis. How-
ever, some other studies demonstrated otherwise [18,19],
which may reflect on the precise nature of sample types
being analysed, in that optimum selection of reference
genes depends on the specific cohort of samples, the
method used to retrieve these samples and sample prepa-
ration and treatments.
For instance, the expression of beta-actin was found up-
regulated in liver tumour samples when compared with
normal liver samples, implying a correlation between
over-expression of beta-actin and oncogenesis in
hepatoma [20]. On the other hand, HSP60, belongs to the
HSP family and the members of this family are frequently
dysregulated in malignant conditions [21]. For instance,
HSP60 was over-expressed in colorectal [22] and cervical
[23] cancers, but down-regulated in urinary bladder can-
cer [21]. However, these observations are controversial
and are contrary to our findings that have been performed
in a larger cohort study. Indeed, beta-actin has been
widely used as an internal reference gene/protein in real-
time PCR and western blotting in liver tissues or others.
Our data also revealed that the proposed reference mark-
ers (ACTB and HSP60) were expressed equivalently in dis-
eased or healthy tissues by 2-DE profiling, western blot,
IHC, Q-PCR and mathematical modelling. In fact, HMBS
was initially used as an internal control for validation of
the two potential reference marker candidates mainly
because HMBS was previously suggested to be the single
best reference gene for gene expression studies in HCC
[12]. The reference gene was subsequently included for
evaluation together with other conventional reference
genes and the two potential reference candidates identi-
fied from our study. ACTB and HSP 60 were identified to
be superior to HMBS as references candidates for HCC
gene expression studies (Table 4). Therefore, it is believed
The pairwise variation (Vn/n+1) analysisFigure 3
The pairwise variation (Vn/n+1) analysis. The relative expressions of the 8 reference genes were assayed using Q-PCR and 
the pair-wise variation values (V) were determined using geNorm algorithm in order to find the optimum number of reference 
genes required for accurate data normalization.
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in basic cellular structure and functions regardless of the
pathophysiological states.
The discovery that protein abundance of ACTB and
HSP60 across diseased and healthy tissues are similarly
analogous is important because imprecise sampling
between diseased and healthy tissue, and the inherently
heterogeneous nature of liver tissues is not a point for
conjecture when measuring dysregulation of disease asso-
ciated proteins relative to these very stably expressed
housekeeping proteins. Protein levels were confirmed
using 2-DE, immunoblotting and immunohistochemis-
try. These methods are not renowned for their ability to
quantify proteins, while methodological approaches
improve [8], this study has drawn on the quantitative
power offered by two qPCR procedures. Moreover, the
present study has been careful to use ANOVA analysis of
2-DE gels and has gone further to show a close positive
correlation between protein and mRNA abundance for
the reference candidates ACTB and HSP60. The detailed
application of protein and mRNA extraction and analysis
as shown in this study may provide for a generic means to
better correlate transcript level to protein production, and
could possibly lead to the prediction of dys-regulated pro-
teins related to pathogenesis from mRNA screens.
Conclusion
The use of reference molecules with stable expression
across tissue sample cohorts is important in clinical
research, particularly when the expression levels of certain
molecules are compared and used to predict pathological
conditions [24]. Our results demonstrated the high
expression stability of ACTB and HSP60 in human liver
tissues both in protein and transcript levels and their pos-
itive correlation in human liver samples. Moreover, using
geNorm algorithm showed at least 2 reference markers
were recommended for data normalization. A prospec-
tive, multicenter study is under way for validation of this
protein-based set of reference markers in high-risk popu-
lation for HCC.
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